Kecheng Huang - Concepedia

Author

Kecheng Huang

Huazhong University of Science and Technology

Also Known As

HUST, Jun Yang, K. -G. Huang, Ke-Cheng Huang, Kecheng Huang

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Huazhong University of Science and Technology Tongji Hospital Central Hospital of Wuhan Wuhan University Women's Hospital, School of Medicine, Zhejiang University

About

Kecheng Huang is an author at Huazhong University of Science and Technology specializing in medicine, public health, and cervical cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	413
2	Public Health	7	7	357
3	Diabetes	2	2	98
4	Cell Biology	1	1	56
5	Endocrinology	1	1	48

Kecheng Huang

Publications

937

Citations

H-Index

Page 1

	Year	Citations
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12 Yongyong Shi, Li Li, Zhibin Hu, Nature Genetics Genome-wide Association StudyCervical CancerCervical HealthGeneticsGenetic Epidemiology	2013	148
Changes in Prevalence and Clinical Characteristics of Cervical Cancer in the People's Republic of China: A Study of 10,012 Cases From a Nationwide Working Group Shuang Li, Ting Hu, Weiguo Lv, The Oncologist	2013	96
Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression Zongyuan Yang, Xin Yang, Sen Xu, Molecular Cancer	2017	73
Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria Ting Hu, Shuang Li, Yile Chen, European Journal of Cancer	2012	70
The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway Zhilan Chen, Shuang Li, Kecheng Huang, Human Pathology Cervical CancerEpithelial-mesenchymal Transition PathwayMedicinePathologyLymph Node Metastasis	2013	56
Role of Drugs Used for Chronic Disease Management on Susceptibility and Severity of COVID‐19: A Large Case‐Control Study Huadong Yan, Ana M. Valdes, Amrita Vijay, Clinical Pharmacology & Therapeutics Disease ManagementHypertensionCardiometabolic RiskCardiovascular PharmacologyPharmacotherapy	2020	56
Can Inhibin B Reflect Ovarian Reserve of Healthy Reproductive Age Women Effectively? Jingyi Wen, Kecheng Huang, Xiaofang Du, Frontiers in Endocrinology	2021	52
Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (>=4 cm) stage IB and IIA cervical carcinoma Huei-Jean Huang, T. -C. Chang, Ji-Chen Hong, International Journal of Gynecological Cancer	2003	49
Age-Specific Normal Reference Range for Serum Anti-Müllerian Hormone in Healthy Chinese Han Women: A nationwide Population-Based Study Xiaofang Du, Ting Ding, Hanwang Zhang, Reproductive Sciences Hormonal ContraceptiveOvarian AgingNationwide Population-based StudyReproductive HealthGynecology	2016	48
Development of Criteria for Ovarian Preservation in Cervical Cancer Patients Treated with Radical Surgery With or Without Neoadjuvant Chemotherapy: A Multicenter Retrospective Study and Meta-analysis Ting Hu, Li Wu, Hui Xing, Annals of Surgical Oncology Gynecologic SurgeryCervical Cancer ManagementSurgical OncologyCervical CancerNeoadjuvant Chemotherapy	2012	42

Page 1